This large multi-national pharmaceutical company has more than 100,000 employees across more than 100 countries. The company’s main line of business is researching, developing and introducing new drugs. The company sought to accelerate its Clinical Trials processes.
In the constant quest for the new therapeutics, this industry giant runs hundreds of clinical trials at any given time, all around the world, across different products, at different stages, with multiple Clinical Investigators for each one. The faster they can get new trials started, the longer the potential window for commercial sale of the next block-buster drug under patent.
With the ultimate goal of faster time-to-market, the company implemented Appian across its clinical trials processes, including Form-1572, Global CRO Contracts Management and Study Start-Up. The solution delivers a unified view – which was previously unattainable – of which products are being tested where, what stage each trial has reached, and the status of all required filings with the various governing bodies in different countries around the globe. Across all trials, across all products, across all trial sites. Appian cut the submission time for start-up documentation submission from 20 days to 4 days.